Toward neuroprotective treatments of Parkinson’s disease [Neuroscience]

Parkinson's disease (PD) is, after Alzheimer's disease, the second most-common neurodegenerative disorder affecting 1–2% of the global population over the age of 65 (1, 2). Aging being a primary risk factor for PD (3), its economic burden on our society in terms of medical care will escalate with our aging...

http://ift.tt/2nBDfr0